Brain-disabling treatments in psychiatry : drugs, electroshock, and the psychopharmaceutical complex / Peter R. Breggin.
Material type: TextPublication details: New York : Springer Pub., 2008.Edition: 2nd edDescription: xxx, 546 p. ; 24 cmISBN:- 9780826129345 (alk. paper)
- 082612934X (alk. paper)
- United States. Food and Drug Administration
- United States. Food and Drug Administration
- Psychotropic drugs -- Side effects
- Brain -- Effect of drugs on
- Electroconvulsive therapy -- Complications
- Iatrogenic diseases
- Mental Disorders -- therapy -- United States
- Brain Damage, Chronic -- etiology -- United States
- Drug Industry -- United States
- Electroconvulsive Therapy -- adverse effects -- United States
- Psychotropic Drugs -- adverse effects -- United States
- 616.89/122 22
- RC483 .B72 2008
Item type | Current library | Call number | Status | Notes | Date due | Barcode | |
---|---|---|---|---|---|---|---|
General circulation | Main Campus Library General Stacks | RC483 .B72 2008 (Browse shelf(Opens below)) | Available | amm | 2015/000735 |
Includes bibliographical references (p. 463-526) and index.
The brain-disabling, spellbinding effects of psychiatric drugs -- Deactivation syndrome (chemical lobotomy) caused by neuroleptics -- neuroleptic-induced anguish, including agitation, despair, and depression -- Severe and potentially irreversible neurological syndromes (tardive dyskinesia and neuroleptic malignant syndrome) caused by neuroleptics -- Neuroleptic-induced neurotoxicity, brain damage, persistent cognitive deficits, dementia, and psychosis -- Recent developments in antidepressant label changes -- Antidepressant-induced mental, behavioral, and cerebral abnormalities -- Lithium and other drugs for bipolar disorder -- Electroconvulsive therapy (ECT) for depression -- From attention-deficit/hyperactivity disorder (ADHD) to bipolar disorder : diagnosing America's children -- Stimulant-induced brain damage, brain dysfunction, and psychiatric adverse reactions -- Antianxiety drugs, including behavioral abnormalities caused by Xanax and Halcion -- The Food and Drug Administration (FDA) and the National Institute of Mental Health (NIMH) : drug company advocates -- Drug company deceptions -- How to more safely stop taking psychiatric drugs -- Failed promises, last resorts, and psychotherapy.
There are no comments on this title.